Comparison between Invicta Diagnostic IPO and Shreeji Global FMCG IPO.
Invicta Diagnostic IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Shreeji Global FMCG IPO is a SME Bookbuilding proposed to list at NSE SME.
| Invicta Diagnostic IPO | Shreeji Global FMCG IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Socradamus Capital Pvt.Ltd. | Interactive Financial Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Nikunj Stock Brokers Ltd. | B.N.Rathi Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Invicta Diagnostic IPO is up to ₹26.71 Cr whereas the issue size of the Shreeji Global FMCG IPO is up to ₹80.75 Cr. The final issue price of Invicta Diagnostic IPO is ₹85.00 per share and of Shreeji Global FMCG IPO is ₹125.00 per share.
| Invicta Diagnostic IPO | Shreeji Global FMCG IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹80.00 per share | ₹120.00 per share |
| Issue Price (Upper) | ₹85.00 per share | ₹125.00 per share |
| Issue Price (Final) | ₹85.00 per share | ₹125.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1000 shares |
| Fresh Issue Size | 31,42,400 shares | 64,60,000 shares |
| Fresh Issue Size (Amount) | up to ₹26.71 Cr | up to ₹80.75 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 31,42,400 shares | 64,60,000 shares |
| Issue Size Total (Amount) | up to ₹26.71 Cr | up to ₹80.75 Cr |
Invicta Diagnostic IPO opens on Dec 01, 2025, while Shreeji Global FMCG IPO opens on Nov 04, 2025. The closing date of Invicta Diagnostic IPO and Shreeji Global FMCG IPO is Dec 03, 2025, and Nov 07, 2025, respectively.
| Invicta Diagnostic IPO | Shreeji Global FMCG IPO | |
|---|---|---|
| Anchor Bid Date | Nov 28, 2025 | Nov 03, 2025 |
| Issue Open | Dec 01, 2025 | Nov 04, 2025 |
| Issue Close | Dec 03, 2025 | Nov 07, 2025 |
| Basis Of Allotment (Tentative) | Dec 04, 2025 | Nov 10, 2025 |
| Initiation of Refunds (Tentative) | Dec 05, 2025 | Nov 11, 2025 |
| Credit of Share (Tentative) | Dec 05, 2025 | Nov 11, 2025 |
| Listing date (Tentative) | Dec 08, 2025 | Nov 12, 2025 |
| Anchor Lockin End date 1 | Jan 02, 2026 | Dec 09, 2025 |
| Anchor Lockin End date 2 | Mar 03, 2026 | Feb 07, 2026 |
Invicta Diagnostic IPO P/E ratio is 14.51, as compared to Shreeji Global FMCG IPO P/E ratio of 16.42.
| Invicta Diagnostic IPO | Shreeji Global FMCG IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Invicta Diagnostic Ltd.'s revenue increased by 90% and profit after tax (PAT) rose by 30% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Shreeji Global FMCG Ltd.'s revenue increased by 11% and profit after tax (PAT) rose by 122% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 90.52 | 99.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.69 | 70.12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.51 | 16.42 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹106.86 Cr. | ₹284.50 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 44.28% | 51.74% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 42.00% | 32.07% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.26 | 1.03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.86 | ₹7.61 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 36.25% | 41.11% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Invicta Diagnostic IPO Retail Individual Investors (RII) are offered 12,67,200 shares while in Shreeji Global FMCG IPO retail investors are offered 12,67,200 shares. Qualified Institutional Buyers (QIB) are offered 5,34,400 shares in Invicta Diagnostic IPO and 7,76,000 shares in Shreeji Global FMCG IPO.
| Invicta Diagnostic IPO | Shreeji Global FMCG IPO | |
|---|---|---|
| Anchor Investor Reservation | 7,98,400 shares | 11,62,000 shares |
| Market Maker Reservation | 1,66,400 shares | 3,40,000 shares |
| QIB | 5,34,400 shares | 7,76,000 shares |
| NII | 5,42,400 shares | 13,56,000 shares |
| RII | 12,67,200 shares | 31,66,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 31,42,400 shares | 64,60,000 shares |
Invicta Diagnostic IPO subscribed 4.27x in total, whereas Shreeji Global FMCG IPO subscribed 3.27x.
| Invicta Diagnostic IPO | Shreeji Global FMCG IPO | |
|---|---|---|
| QIB (times) | 3.51x | 1.64x |
| NII (times) | 6.96x | 5.06x |
| Big NII (times) | 7.30x | 6.16x |
| Small NII (times) | 6.27x | 2.85x |
| RII (times) | 3.44x | 2.91x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 4.27x | 3.27x |
